David Simpson

David Simpson serves as CEO at Iksuda Therapeutics. Iksuda Therapeutics operates in the research sector with approximately 43.0 employees. The company is headquartered in Rowlands Gill, England. Iksuda Therapeutics generates annual revenue of 2500000.0. To date, Iksuda Therapeutics has raised 73886299.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 10,137 executive contacts are available in England.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Outlook Microsoft Office 365 CloudFlare Hosting Mobile Friendly Google Tag Manager reCAPTCHA Render AI

antibodydrug conjugates permalink conjugation chemistry cancer research adcs drug development therapeutics antibodies toxins cancer treatment adc stability antibody drug conjugate drug discovery biotechnology preclinical bioconjugation organic synthesis clinical cell biology chemistry licencing biotechnology research antibody-drug conjugates adc development tumor-selective activation payload delivery cancer therapy design principles clinical trials targeted therapy oncology innovations differentiated technology pipeline development tumor specificity payload mechanisms novel linkers drug conjugates anti-cancer efficacy patient safety b-cell malignancies her2-targeting gi tumors solid tumors non-hodgkin lymphoma clinical-stage adcs therapeutic index collaborative partnerships drug loading bioengineering tumor-selective payloads research collaborations precision oncology advanced tumor therapy drug resistance solutions high unmet need cancers prodrug mechanisms treatment paradigms biologics manufacturing adc innovation safety profiles advanced linkers novel payloads immunotherapy cancer indications preclinical studies therapeutic options target identification clinical utility multi-platform approach in-house capabilities health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like David Simpson in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Iksuda Therapeutics.

How do I reach David Simpson directly?

David Simpson's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Iksuda Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does David Simpson work for?

David Simpson is CEO at Iksuda Therapeutics, a company in the research sector with 43.0 employees. The company is based in Rowlands Gill, England.

Can I pitch or sell to David Simpson?

As CEO at Iksuda Therapeutics, David Simpson is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach David Simpson directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is David Simpson in?

David Simpson works in the research industry as CEO at Iksuda Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is David Simpson's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. David Simpson's profile is kept up-to-date with the latest available information.

Last updated: May 12, 2026